Antiviral drug resistance is one of the most common problems in medicine, and, therefore, finding new antiviral agents, especially from natural resources, seems to be necessary. This study was designed to assay the antiviral activity of curcumin and its new derivatives like gallium-curcumin and Cu-curcumin on replication of HSV-1 in cell culture. The research was performed as an in vitro study in which the antiviral activity of different concentrations of three substances including curcumin, Gallium-curcumin and Cu-curcumin were tested on HSV-1. The cytotoxicity of the tested compounds was also evaluated on the Vero cell line. The CC 50 values for curcumin, gallium-curcumin and Cu-curcumin were 484.2 µg/mL, 255.8 µg/mL and 326.6 µg/mL, respectively, and the respective IC 50 values 33.0 µg/mL, 13.9 µg/mL and 23.1 µg/mL. The calculated SI values were 14.6, 18.4 and 14.1, respectively. The results showed that curcumin and its new derivatives have remarkable antiviral effects on HSV-1 in cell culture.
Viral diseases have always been a major health problem and scientists have continually tried to find new antiviral compounds. Cold sores, one of these viral diseases, are caused by herpes simplex virus type 1 (HSV-1), which is a DNA virus of the herpesviridae family [1] .
Most complications caused by HSV-1 are self-limited, but HSV-1 can establish lifelong latent infection in sensory ganglia and some factors will cause the reactivation of the virus [2] . Herpes simplex virus-1 infection is common worldwide, with 45% to 98% of the world population being infected in different populations [1, 2] . Due to the high prevalence of HSV-1 infections, several antiviral drugs have been developed for the treatment of HSV-1 infections, but many of them show severe side effects and are unable to cure the infections completely. Nearly all clinically effective antiviral drugs are nucleoside analogues. However, following a long period of their use, drug resistance has emerged [3] . Therefore, finding novel anti HSV-1 agents with low side effects is necessary. It has been suggested that natural products from plants can exhibit anti HSV-1 activities. Such natural products need to be isolated and screened for their potential to act as antiviral compounds [4] . One of these natural antiviral agents is curcumin, a major antioxidant compound and a principal constituent of the spice turmeric (Curcuma longa) [5] , a native plant from south India and Indonesia. This spice has been used for hundreds of years for flavoring and coloring of many kinds of foods and is also used as a food preservative [6, 7] .
Regarding the use of turmeric in Indian and Chinese traditional medicine many scientists are interested to reveal the therapeutic and biological functions of this compound. Curcumin can affect the metabolism of cells and organisms [8] . Also, it has anti-tumor, antioxidant, antiinflammatory, antiviral and anti-infectious properties [6, [9] [10] [11] [12] . Although various antiviral effects of curcumin have been reported, more studies are necessary to develop it as an alternative antiviral drug for HSV-1 treatment or for providing a template for the synthesis of new anti HSV-1 agents [13] .
In this study, we evaluated the in vitro anti-HSV-1 activity of curcumin and its novel derivatives galliumcurcumin and Cu-curcumin. Based on our knowledge, there has been no study of the antiviral activity of these last two compounds.
The cytotoxicities of curcumin, gallium-curcumin and Cu-curcumin on Vero cells were determined by calculation of their CC 50 values as 484.2, 255.8 and 326.6 μg/mL, respectively. Regarding the collected data for the antiviral activity of curcumin (Table 1) , galliumcurcumin (Table 2) , and Cu-curcumin (Table 3) against HSV-1 in cell culture, the IC 50 values of these compounds, calculated using STATA software, were 33.0, 13.9 and 23.1 μg/mL, respectively. As shown in Tables 1, 2 and 3, 12 μg/mL of curcumin, 4 μg/mL gallium-curcumin and 8 μg/mL of Cu-curcumin could not prevent CPE presentation, which is related to HSV-1 replication in cell culture. However, 54 μg/mL of curcumin, 30 μg/mL of gallium-curcumin and 42 μg/mL of Cu-curcumin totally prevented viral CPE presentation. Based on our knowledge, no research has been reported up to now on the activity of the new derivatives of curcumin, Cu-curcumin and gallium-curcumin against viruses, especially HSV-1.
Antibacterial activities of curcumin and curcuminoids have been reported [14] . Curcumin has also been shown to inhibit the growth of several types of viruses and malignant cells [15] . Curcumin can inhibit the expression of immediate early genes of HSV-1 [8] , and also inhibit the activity of HIV-1 integrase, which is necessary for replication of this virus [16] . Various derivatives related to curcumin were synthesized and tested as inhibitors of the replication cycle of some viruses [17] . Synthetic modification of antiviral agents in order to improve either their antiviral activity or pharmacological properties is of interest [18] . Therefore, two new complexes, Cu-curcumin and gallium-curcumin, were chosen for the present study.
In this study, the CC 50 values obtained showed that the cytotoxicity of curcumin is less than those of its new derivatives gallium-and copper-curcumins. Based on the differences in the CC 50 values of gallium-curcumin and Cu-curcumin it could be concluded that the gallium compound was more cytotoxic than the copper one to Vero cells.
In most studies, DMSO showed antiviral and cytotoxic effects in vitro on different cell types [19] . Thus we tested the probable DMSO cytotoxic and virucidal effects in the current study. The concentration of DMSO used in our study was less than 2%, which is the lowest concentration for an antiviral effect; therefore we ignored the effect of DMSO in our study.
Based on the data obtained, it could be concluded that curcumin and its new derivatives exhibited in vitro anti-HSV-1 activities. Such agents could be developed either as anti HSV-1 compounds or provide a template for the synthesis of new anti HSV-1 agents. Our results can be considered as an early step in elucidating the molecular basis of the antiviral activities of curcumin. Future research is necessary to determine the possible in vivo anti-HSV-1 activity of curcumin and its related derivatives. Also, the mechanism(s) of action of these compounds should be revealed in future studies.
Experimental

Cell and virus:
The African green monkey kidney cell line (Vero) was used as an appropriate cell line for Antiviral activity of curcumin derivatives Natural Product Communications Vol. 5 (12) 2010 1937
HSV-1 propagation. The cells were cultured using Dulbecco minimum essential medium (Gibco) containing 10% fetal bovine serum (Gibco). The antiviral activity assay was carried out on the KOS strain of HSV-1. The virus was propagated in Vero cells and the titer of propagated viral stock was firmed as TCID 50 mL -1 by using Karber's method. After titration, viral stock was dispensed in sterile tubes, which were stored at -70°C until the date of use.
Preparation of curcumin and its derivatives:
Curcumin was purchased from Sigma, and the curcumin derivatives were prepared as previously described [20] . Dimethyl sulfoxide (DMSO) was used as the solvent for curcumin and its derivatives.
Cytotoxicity assay:
Cytotoxicity values of all compounds were determined by culturing Vero cells for 96 h in the presence of increasing amounts of each substance. Three wells for each concentration of each compound were used. Viable cells were determined by the trypan blue exclusion test. Results were plotted as a dose response curve and 50% cell growth inhibitory concentration (CC 50 ) was obtained by using STATA modeling software.
Antiviral activity assay:
The cytopathic inhibiton assay was used to determine the semi-quantitative antiviral activity of each test compound. Briefly, Vero cells were grown in a 96-well cell culture microplate (2×10 3 cells/well). The cultured plates were incubated at 37 o C in the presence of 5% CO 2 until the cells showed 80% confluency. Subsequently, the culture medium was removed from each well and 100 TCID 50 of virus suspension and different concentrations of curcumin and its derivatives from minimal to maximal noncytotoxic concentrations were added to each well of the cell culture microplate. For each concentration of curcumin and its derivatives 4 wells were chosen.
For the virus control, 100 TCID 50 with the highest amount of DMSO which did not show cytotoxicity were added to 4 wells. Also, in each microplate, 4 wells were treated with DMSO without virus as a negative control for virus. In addition, 4 wells of each row were treated with the highest level of each curcumin based compound which did not previously exhibit cytotoxicity.
The plates were incubated at 37°C in a humidified CO 2 atmosphere (5% CO 2 ) and were investigated every day for cytopathic effect (CPE) presentation up to 5 days post infection.
The degree of inhibition was expressed as percent yield of virus control (% virus control = CPE experimental group/CPE virus control × 100). The concentration of each compound which reduced 50% of CPE presentation with respect to virus control was estimated from graphic plots defined as 50% inhibited concentration (IC 50 ) expressed in μg per mL by using STATA modeling software. The selectivity index (SI) was measured from the ratio of CC 50 /IC 50 [21, 22] .
Statistical analysis:
The STATA statistical analysis package was used for curve plotting in order to calculate IC 50 and CC 50 values.
